Epigenetics and In Silico Transcriptome Analysis of Pediatric Acute Myeloid Leukemia
European Journal of Haematology · 2026
DOI: 10.1111/ejh.70230 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Haematology, 2026. Verfasst von Akram N Salah und 11 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology and Immunology Department, Faculty of Pharmacy, Badr University in Cairo (BUC), Badr City, Egypt. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Epigenesis, Genetic, Gene Expression Profiling, Gene Expression Regulation, Leukemic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Pediatric acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy that accounts for about 15%–20% of childhood leukemias. Despite therapeutic advances, relapses remain common, and survival for high‐risk patients is below 60%. Unlike adult AML, pediatric AML displays distinct genetic mutations, including FLT3‐ITD, NPM1, KMT2A rearrangements, and core‐binding factors (CBF) fusions, as well as extensive epigenetic dysregulation. Aberrant DNA methylation, histone modifications, and altered non‐coding RNA expressions disrupt hematopoietic differentiation and activate oncogenic transcriptional networks. Recent advances in silico transcriptomic analysis have transformed the study of pediatric AML by integrating gene expression and epigenetic data to identify molecular drivers and regulatory networks. Computational RNA‐seq pipelines and pathway analyses have highlighted key epigenetic regulators, including DNMT3A, TET2, and HDACs, as potential therapeutic targets. Multi‐omics approaches combining transcriptomic, methylomic, and chromatin accessibility data are increasingly used to define biomarkers for diagnosis, prognosis, and therapeutic response. This review provides a comprehensive overview of the molecular and epigenetic landscape of pediatric AML, emphasizing the power of in silico transcriptome analysis to uncover disease mechanisms, refine patient stratification, and guide the development of precision‐based epigenetic therapies aimed at improving long‐term outcomes in children with AML.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Microbiology and Immunology Department, Faculty of Pharmacy, Badr University in Cairo (BUC), Badr City, Egypt.
- Molecular Biology and Biotechnology Department, School of Biotechnology, Badr University in Cairo (BUC), Badr City, Egypt.
- Zoology and Entomology Department, Faculty of Science, Helwan University, Helwan, Egypt.
- Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
- Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Badr University in Cairo (BUC), Badr City, Egypt.
- Department of Biochemistry, Faculty of Pharmacy, Egyptian Russian University, Badr City, Egypt.
ORCID-Profile: Reda M Mansour, Gharieb S El-Sayyad, Hend H Mohamed, Osama A Mohammed, Ahmed S Doghish
Zitieren
APA
Salah, A. N., Mansour, R. M., El-Sayyad, G. S., Moustafa, H. A. M., Sayed, G. A., Mohamed, H. H., Elshami, N. H., AlFarsi, K., Fahim, A., Mohammed, O. A., Rudayni, H. A., & Doghish, A. S. (2026). Epigenetics and In Silico Transcriptome Analysis of Pediatric Acute Myeloid Leukemia. European Journal of Haematology. https://doi.org/10.1111/ejh.70230
Vancouver
Salah AN, Mansour RM, El-Sayyad GS, Moustafa HAM, Sayed GA, Mohamed HH, et al. Epigenetics and In Silico Transcriptome Analysis of Pediatric Acute Myeloid Leukemia. European Journal of Haematology. 2026. doi:10.1111/ejh.70230
BibTeX
@article{Salah2026,
author = {Salah, Akram N and Mansour, Reda M and El-Sayyad, Gharieb S and Moustafa, Hebatallah Ahmed Mohamed and Sayed, Ghadir A and Mohamed, Hend H and Elshami, Nourhan H and AlFarsi, Kareem and Fahim, Ahmed and Mohammed, Osama A and Rudayni, Hassan A and Doghish, Ahmed S},
title = {Epigenetics and In Silico Transcriptome Analysis of Pediatric Acute Myeloid Leukemia},
journal = {European Journal of Haematology},
year = {2026},
doi = {10.1111/ejh.70230}
}
EUVIMED